Nanochon Revenue and Competitors

Burke, VA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Nanochon's estimated annual revenue is currently $1.7M per year.(i)
  • Nanochon's estimated revenue per employee is $155,000

Employee Data

  • Nanochon has 11 Employees.(i)
  • Nanochon grew their employee count by 0% last year.

Nanochon's People

NameTitleEmail/Phone
1
Co-Founder and CTOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.4M9-10%N/AN/A
#2
$4.3M284%N/AN/A
#3
$1.1M70%N/AN/A
#4
$3.5M45-52%$56.5MN/A
#5
$0.3M20%N/AN/A
#6
$4.5M2921%N/AN/A
#7
$1.9M129%N/AN/A
#8
$7M455%N/AN/A
#9
$6.7M435%N/AN/A
#10
$2M13-13%N/AN/A
Add Company

What Is Nanochon?

Today, there is a solid clinical standard for treating joint disease: the total joint replacement. Yet, while the surgical devices and techniques used to implant them have been largely perfected, today’s standard replacement joints don’t last forever. The limited lifespan of common replacement joints limits their use to patients aged 55 or older. This leaves patients between ages 18 and 55 suffering from cartilage damage, traumatic injury, or early stage cartilage loss with limited treatment options. Our company, Nanochon, is developing an implant that is designed to not only replace lost and damaged cartilage, but also to encourage new tissue growth. Using 3-D printing and a novel material, the Nanochon implant is a sturdy medical advancement that is both an orthopedic load bearing implant as well a tissue growth scaffold. The Nanochon implant has the potential to deliver faster and more successful recoveries for patients,while reducing costs to health providers, payers, and patients. Nanochon’s aim is to set a new clinical standard for cartilage restoration.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M157%N/A
#2
$2.6M21-5%N/A
#3
$7.1M3310%N/A
#4
$4.4M389%N/A
#5
$16.1M587%N/A